CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park

Clin Mol Hepatol. 2016;22(1):152-159. Published online 2016 March 28 DOI: https://doi.org/10.3350/cmh.2016.22.1.152

Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis

Won Hyeok Choe, So Young Kwon, Byung Kook Kim, Soon Young Ko, Jong Eun Yeon, Kwan Soo Byun, Gyun-Hwan Kim, Chang Hong Lee

Liver International. 2008;28(6):814-820

Link1

516 Is tenofovir plus lamivudine superior to tenofovir monotherapy in patients with HBV/HIV coinfection?

Journal of Hepatology. 2005;42:187

Link1 Link2

Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B

Chan Ho Park, Seok Won Jung, Jung Woo Shin, Mi Ae Bae, Yoon Im Lee, Yong Tae Park, Hwa Sik Chung, Neung Hwa Park

Clinical and Molecular Hepatology. 2016;22(1):152-159

Link1

Link2 Link3

Dolutegravir/lamivudine/tenofovir/efavirenz/lamivudine/tenofovir

Reactions Weekly. 2019;1734(1):187-187

Link1

Link2 Link3

Efficacy of Combination Tenofovir Plus Lamivudine Versus Tenofovir Monotherapy in Patients With Chronic Hepatitis B Virus

Frederick J. Glyn, Upkar Gill, William Alazawi, Valerie Ross, Paul Kooner, Richard Marley, Graham Foster, Patrick T. Kennedy

Gastroenterology. 2011;140(5):S-455

Link1 Link2

Treatment of Lamivudine-resistant chronic hepatitis B with tenofovir

Clark C. Kulig, James F. Trotter, Gregory T. Everson

Gastroenterology. 2003;124(4):A763

Link1 Link2

Comparison of lamivudine monotherapy with lamivudine plus interferon alpha combination in patients with HBeAg positive chronic hepatitis B

Z Karasu

Journal of Hepatology. 2001;34:177-178

Link1 Link2

Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance

S. Lee, S. H. Ahn, K. S. Jung, D. Y. Kim, B. K. Kim, S. U. Kim, O. Baatarkhuu, H. J. Ku, K. Han, J. Y. Park

Journal of Viral Hepatitis. 2016;24(2):141-147

Link1 Link2 Link3

Rescue therapy for lamivudine-resistant chronic hepatitis B: Comparison between entecavir 1.0 mg monotherapy, adefovir monotherapy and adefovir add-on lamivudine combination therapy

Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim

Journal of Gastroenterology and Hepatology. 2010;25(8):1374-1380

Link1

P1491 Interferon plus lamivudine in treatment of chronic hepatitis B in patients unresponsive to lamivudine monotherapy

M. Panahi, A. Heydari

International Journal of Antimicrobial Agents. 2007;29:S417

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.